Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
BackgroundTo construct a prediction model consisting of metabolites and proteins in peripheral blood plasma to predict whether patients with unresectable stage III and IV non-small cell lung cancer can benefit from immunotherapy before it is administer…